Trial Profile
Enoxaparin versus unfractionated heparin in PCI [percutaneous coronary interventions]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2007
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary) ; Heparin
- Indications Acute coronary syndromes; Coronary thrombosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms ZEUS
- 03 Apr 2007 New trial record.